2024-03-28T23:22:46Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_66E41448CF49
2024-03-23T02:28:24Z
serval:BIB_66E41448CF49
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis
10.1097/01.ASN.0000092789.67966.5C
000186073500020
14569096
Lods
N.
author
Ferrari
P.
author
Frey
F. J.
author
Kappeler
A.
author
Berthier
C.
author
Vogt
B.
author
Marti
H. P.
author
article
2003-11
Journal of the American Society of Nephrology
1046-6673
journal
14
11
2861-72
Adult
*Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors/*administration & dosage
Biphenyl Compounds/*administration & dosage
Case-Control Studies
Chronic Disease
Cross-Over Studies
Drug Therapy, Combination
Female
Fosinopril/*administration & dosage
Glomerulonephritis/*metabolism
Humans
Male
Matrix Metalloproteinases/drug effects/*metabolism
Middle Aged
Polycystic Kidney, Autosomal Dominant/metabolism
Prospective Studies
Tetrazoles/*administration & dosage
60_published
true
Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't --- Old month value: Nov